Effect of Empagliflozin on Kidney Biochemical and Imaging Outcomes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure with Reduced Ejection Fraction (SUGAR-DM-HF).

Authors :: Lee, Matthew M.Y.
Gillis, Keith A.
Brooksbank, Katriona J.M.
Allwood-Spiers, Sarah
Hall Barrientos, Pauline
Wetherall, Kirsty
Roditi, Giles
AlHummiany, Bashair
Berry, Colin
Campbell, Ross T.
Chong, Victor
Coyle, Liz
Docherty, Kieran F.
Dreisbach, John G.
Kuehn, Bernd
Labinjoh, Catherine
Lang, Ninian N.
Lennie, Vera
Mangion, Kenneth
McConnachie, Alex
Source :: Circulation; 7/26/2022, Vol. 146 Issue 4, p364-367, 4p
Publication Year :: 2022

Full Text Access

Tools